These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29165345)

  • 1. Activity In Vitro of Clotrimazole against Canine Methicillin-Resistant and Susceptible Staphylococcus pseudintermedius.
    Frosini SM; Bond R
    Antibiotics (Basel); 2017 Nov; 6(4):. PubMed ID: 29165345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma.
    Clark SM; Loeffler A; Bond R
    J Antimicrob Chemother; 2015 Jul; 70(7):2048-52. PubMed ID: 25749003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of chlorhexidine with trisEDTA or miconazole in vitro against canine meticillin-resistant and -susceptible Staphylococcus pseudintermedius isolates from two UK regions.
    Clark SM; Loeffler A; Schmidt VM; Chang YM; Wilson A; Timofte D; Bond R
    Vet Dermatol; 2016 Oct; 27(5):340-e84. PubMed ID: 27406860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity of mangosteen (Garcinia mangostana Linn.) crude extract against Staphylococcus pseudintermedius isolates from canine pyoderma.
    Larsuprom L; Rungroj N; Lekcharoensuk C; Pruksakorn C; Kongkiatpaiboon S; Chen C; Sukatta U
    Vet Dermatol; 2019 Dec; 30(6):487-e145. PubMed ID: 31441182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs.
    Valentine BK; Dew W; Yu A; Weese JS
    Vet Dermatol; 2012 Dec; 23(6):493-e95. PubMed ID: 23050904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Activity of Some Essential Oils against Methicillin-Susceptible and Methicillin-Resistant
    Nocera FP; Mancini S; Najar B; Bertelloni F; Pistelli L; De Filippis A; Fiorito F; De Martino L; Fratini F
    Animals (Basel); 2020 Oct; 10(10):. PubMed ID: 33019582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro miconazole susceptibility of meticillin-resistant Staphylococcus pseudintermedius and Staphylococcus aureus.
    Weese JS; Walker M; Lowe T
    Vet Dermatol; 2012 Oct; 23(5):400-e74. PubMed ID: 22830415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antimicrobial activity of narasin against common clinical isolates associated with canine otitis externa.
    Chan WY; Hickey EE; Khazandi M; Page SW; Trott DJ; Hill PB
    Vet Dermatol; 2018 Apr; 29(2):149-e57. PubMed ID: 29363210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Antimicrobial Activity of
    Phensri P; Thummasema K; Sukatta U; Morand S; Pruksakorn C
    Animals (Basel); 2022 Nov; 12(22):. PubMed ID: 36428430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro efficacy of the essential oil from Leptospermum scoparium (manuka) on antimicrobial susceptibility and biofilm formation in Staphylococcus pseudintermedius isolates from dogs.
    Song CY; Nam EH; Park SH; Hwang CY
    Vet Dermatol; 2013 Aug; 24(4):404-8, e87. PubMed ID: 23772881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimicrobial activity of miconazole and polymyxin B against canine meticillin-resistant Staphylococcus aureus and meticillin-resistant Staphylococcus pseudintermedius isolates.
    Boyen F; Verstappen KM; De Bock M; Duim B; Weese JS; Schwarz S; Haesebrouck F; Wagenaar JA
    Vet Dermatol; 2012 Aug; 23(4):381-5, e70. PubMed ID: 22409321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control risk factor study of methicillin-resistant Staphylococcus pseudintermedius (MRSP) infection in dogs and cats in Germany.
    Lehner G; Linek M; Bond R; Lloyd DH; Prenger-Berninghoff E; Thom N; Straube I; Verheyen K; Loeffler A
    Vet Microbiol; 2014 Jan; 168(1):154-60. PubMed ID: 24290489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.
    Loeffler A; Baines SJ; Toleman MS; Felmingham D; Milsom SK; Edwards EA; Lloyd DH
    J Antimicrob Chemother; 2008 Dec; 62(6):1301-4. PubMed ID: 18819974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro efficacy of a honey-based gel against canine clinical isolates of Staphylococcus pseudintermedius and Malassezia pachydermatis.
    Oliveira AMP; Devesa JSP; Hill PB
    Vet Dermatol; 2018 Jun; 29(3):180-e65. PubMed ID: 29569291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcome of dogs with meticillin-resistant and meticillin-susceptible Staphylococcus pseudintermedius pyoderma.
    Bryan J; Frank LA; Rohrbach BW; Burgette LJ; Cain CL; Bemis DA
    Vet Dermatol; 2012 Aug; 23(4):361-8, e65. PubMed ID: 22364681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of biofilm-producing Staphylococcus pseudintermedius isolated from healthy dogs in South Korea.
    Han JI; Yang CH; Park HM
    Vet Q; 2015; 35(4):207-10. PubMed ID: 26404519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of olanexidine gluconate in canine superficial pyoderma: a randomised, single-blinded controlled trial.
    Hsiao YH; Imanishi I; Iyori K
    Vet Dermatol; 2021 Dec; 32(6):664-e174. PubMed ID: 34796563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of mupirocin resistance in Staphylococcus pseudintermedius isolates from canine pyoderma in Korea.
    Park JH; Kang JH; Hyun JE; Hwang CY
    Vet Dermatol; 2018 Apr; 29(2):95-e37. PubMed ID: 29363211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimum inhibitory concentration and killing properties of rifampicin against canine Staphylococcus pseudintermedius isolates from dogs in the southeast USA.
    Ho KK; Conley AC; Kennis RA; Hathcock TL; Boothe DM; White AG
    Vet Dermatol; 2018 May; ():. PubMed ID: 29845664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Activity of the Iron-Chelator, DIBI, against Multidrug-Resistant Canine Methicillin-Susceptible
    Nocera FP; Iovane G; De Martino L; Holbein BE
    Pathogens; 2022 Jun; 11(6):. PubMed ID: 35745511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.